Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

SPLIT AMR (Liver Transplant) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn more about antibodies and how they relate to liver health the first year after a transplant.
What is the Condition Being Studied?
Pediatric Liver Transplant

Who Can Participate in the Study?

Pediatric liver transplant patients

Age Group
Children

What is Involved?

If you choose to be in this study your child will:
-Have 1 teaspoon of extra blood drawn at their regular transplant follow-up appointments

Study Details

Full Title
The Early Clinical Impact of DSA Following Pediatric Liver Transplantation: A Multicenter Study
Principal Investigator
Pediatric Liver Transplant Specialist
Protocol Number
IRB: PRO00090686
Phase
Phase N/A
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698